• Transthera Sciences (Nanjing) filed an updated list of directors with the Hong Kong Stock Exchange on June 18, 2026.
• Board lineup: executive directors Dr. Frank Wu, Wu Di; non-executive director Jia Zhongxin; independent non-executive directors Chui Hoi Yam, Li Shu Pai, Feng Weibo.
• Committee roles: Frank Wu chairs the strategy committee; Li Shu Pai chairs the audit committee; Feng Weibo chairs the remuneration and appraisal committee.
• Nomination committee chaired by Chui Hoi Yam; Frank Wu, Feng Weibo serve as members.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences (Nanjing) Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260618-12208782), on June 18, 2026, and is solely responsible for the information contained therein.